Towards eliminating minimal residual disease in ovarian cancer to prevent recurrence
Professor Ahmed Ahmed (NDWRH, University of Oxford)
Tuesday, 07 November 2023, 1pm to 2pm
Hosted by firstname.lastname@example.org
Over the last decade, our research provides strong evidence that the drivers of minimal residual disease (MRD) survival are different from those that drive bulk ovarian cancer. Therefore, eliminating minimal residual disease at the end of traditional treatment requires rationalised therapeutics that specifically target MRD drivers. In this talk I will discuss our recent work in characterising MRD in ovarian cancer and our ongoing work to develop therapeutics to eliminate it.